AU2019902856A0 - Compositions and methods for gene therapy - Google Patents

Compositions and methods for gene therapy

Info

Publication number
AU2019902856A0
AU2019902856A0 AU2019902856A AU2019902856A AU2019902856A0 AU 2019902856 A0 AU2019902856 A0 AU 2019902856A0 AU 2019902856 A AU2019902856 A AU 2019902856A AU 2019902856 A AU2019902856 A AU 2019902856A AU 2019902856 A0 AU2019902856 A0 AU 2019902856A0
Authority
AU
Australia
Prior art keywords
compositions
methods
gene therapy
therapy
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019902856A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Western Australia
Original Assignee
University of Western Australia
Filing date
Publication date
Application filed by University of Western Australia filed Critical University of Western Australia
Publication of AU2019902856A0 publication Critical patent/AU2019902856A0/en
Abandoned legal-status Critical Current

Links

AU2019902856A 2019-08-09 Compositions and methods for gene therapy Abandoned AU2019902856A0 (en)

Publications (1)

Publication Number Publication Date
AU2019902856A0 true AU2019902856A0 (en) 2019-08-22

Family

ID=

Similar Documents

Publication Publication Date Title
EP3917497A4 (en) Oligonucleotide compositions and methods thereof
EP3374494A4 (en) Crispr compositions and methods of using the same for gene therapy
EP3853357A4 (en) Compositions and methods for manufacturing gene therapy vectors
EP3596213A4 (en) Compositions and methods for enhanced gene expression
EP3781705A4 (en) Compositions and methods for gene editing
EP3983445A4 (en) Compositions and methods for treating cancer
EP3938354A4 (en) Compositions and methods for treating cancer
EP3826666A4 (en) Compositions and methods for treating nrp2-associated diseases
EP3781677A4 (en) Compositions and methods for improved gene editing
EP3976798A4 (en) Compositions and methods for selective gene regulation
EP3841116A4 (en) Fasl immunomodulatory gene therapy compositions and methods for use
EP4090752A4 (en) Plakophillin-2 gene therapy methods and compositions
EP3931336A4 (en) Compositions and methods for treating laminopathies
EP3968785A4 (en) Compositions and methods for treating cancer
EP3908601A4 (en) Methods and compositions for treating cancer
EP3965896A4 (en) Compositions and methods for treating cancer
EP3793566A4 (en) Compositions and methods for reducing spliceopathy and treating rna dominance disorders
EP4003351A4 (en) Methods and compositions for treating cancer
EP4013445A4 (en) Therapeutic protein compositions and methods
EP3959334A4 (en) Hybridization compositions and methods for making and using compositions
EP3917910A4 (en) Therapeutic compounds and compositions
EP3787693A4 (en) Methods of gene therapy
EP3987024A4 (en) Compositions and methods for improved gene editing
EP3958878A4 (en) Conditioning methods for gene therapy
EP3983014A4 (en) Compositions and methods for treating cancer